Attached files
| file | filename |
|---|---|
| 10-K - 10-K - 89bio, Inc. | etnb-10k_20191231.htm |
| EX-32.1 - EX-32.1 - 89bio, Inc. | etnb-ex321_7.htm |
| EX-31.2 - EX-31.2 - 89bio, Inc. | etnb-ex312_6.htm |
| EX-31.1 - EX-31.1 - 89bio, Inc. | etnb-ex311_8.htm |
| EX-23.1 - EX-23.1 - 89bio, Inc. | etnb-ex231_379.htm |
| EX-10.15 - EX-10.15 - 89bio, Inc. | etnb-ex1015_527.htm |
| EX-4.3 - EX-4.3 - 89bio, Inc. | etnb-ex43_293.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-235577 on Form S-8 of our report dated August 15, 2019, except for the retroactive effect of both the 1-for-6.217 reverse stock split and the reorganization, as described in Note 1, as to which the date is October 28, 2019, relating to the financial statements of 89bio, Inc. (operating as 89Bio Ltd. prior to the reorganization described in Note 1), appearing in this Annual Report on Form 10-K for the year ended December 31, 2019.
/s/ Brightman Almagor Zohar & Co.
A Firm in the Deloitte Global Network
Tel Aviv, Israel
March 18, 2020